Loading stock data…
$4.59-0.01 (-0.19%)
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States.
Evolent Health, Inc. in the Healthcare sector is trading at $4.59 with a market capitalization of $529M. Wall Street consensus targets $5.75 (12 analysts), implying a +25.2% move over the next 12 months. The stock is currently 45% below its 52-week high of $8.30, remaining 19.6% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 65/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $652.52M↑ | $496.25M↑ | $468.72M↓ | $479.53M↑ | $444.33M |
| Gross Profit | $80.84M↓ | $83.77M↓ | $97.25M↓ | $99.77M↓ | $100.39M |
| Operating Income | -$9.56M↑ | -$10.60M↑ | -$20.44M↓ | -$1.43M↓ | $2.04M |
| Net Income | -$28.36M↓ | -$26.63M↑ | -$429.13M↓ | -$20.86M↓ | -$19.90M |
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administratio...